Companies/IN/920641

GLENMARK PHARMACEUTICALS LIMITED

Last · NSE₹2250.50-14.80 (-0.65%)close · yahoo · 11h ago
Vol 488.5K ≈ 1.10B
Market cap₹635.1B282.2M sh
P/E · TTM35.3fwd — · eps 63.69
Beta—vs S&P 500
Div yield0.11%annual · TTM
52w range
₹1808.60₹2512.50
Volume488.5Ksession

Issuer

Legal nameGLENMARK PHARMACEUTICALS LIMITED
HQIndia (IN)
ListingIN 920641
ISININE935A01035
SectorHealthcare
IndustryPharmaceuticals
CurrencyINR
Entity registrynse:GLENMARK
Websiteglenmarkpharma.com
LinkedIn
Employees15,800
AddressGlenmark Pharmaceuticals Ltd. Glenmark House 400099, Mumbai +91 22 4018 9999
Headline financial metrics
Revenue₹8.4B
Loading chart…

Upcoming earnings

1 event
11:00 AM UTC+1
Period
Sep 2026
Est. EPS
$15.60
Est. revenue
41.1B
View upcoming earnings →

Earnings transcripts

4 recent

Documents

FormReporting forFiledFlags
quarterly reportGlenmark MDA Q1FY27 vfIR
—2027-03-31≈0
quarterly reportGlenmark Q1 FY27 Earnings Concall InviteIR
—2027-03-31≈0
presentationQ1 FY27 Investor Deck vfIR
—2027-03-31≈0
quarterly reportGlenmark MDA Q4FY26 vfIR
—2026-12-31≈0
presentationQ4 FY26 Investor Deck vfIR
—2026-12-31≈0
Showing 5 of 79 filings